Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00962013
Other study ID # 53
Secondary ID
Status Completed
Phase N/A
First received August 13, 2009
Last updated August 14, 2014
Start date January 2004
Est. completion date December 2011

Study information

Verified date August 2014
Source Stryker Orthopaedics
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.


Description:

The two-piece modular revision stem components are intended to be used for primary or revision total hip arthroplasty, as well as in the presence of severe proximal bone loss. This study evaluates the System in revision cases only. The stems are intended to be used with Stryker Orthopaedics femoral heads, unipolar and bipolar components, and acetabular components. These femoral stems are designed to be press fit into the proximal femur.

In addition to demonstrating survivorship at 5 years, this study will seek to gain information on four secondary objectives: radiographic stability, Harris Hip Scores, SF-36 general well-being assessment, and safety profile.


Recruitment information / eligibility

Status Completed
Enrollment 137
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Candidates for cementless revision of a failed femoral prosthesis.

- Patients willing to sign the informed consent.

- Patients able to comply with follow-up requirements including post-operative weightbearing restrictions and self-evaluations.

- Male and non-pregnant female patients ages 18 to 85 years of age at the time of surgery.

Exclusion Criteria:

- Patients with ongoing infection.

- Patients who are severely immunocompromised.

- Patients who are prisoners.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Restoration® Modular Revision Hip System
Restoration® Modular Revision System

Locations

Country Name City State
United States Crystal Clinic Akron Ohio
United States Orthopedic Associates of Corpus Christi Corpus Christi Texas
United States Iowa Orthopaedic Center Des Moines Iowa
United States New West Sports Medicine and Orthopaedic Surgery Kearney Nebraska
United States Jewish Hospital Center for Advanced Medicine Louisville Kentucky
United States Beth Israel Medical Center New York New York
United States Hospital for Joint Diseases New York New York
United States Orthopaedic Specialty Institute Orange California
United States Rothman Institute Philadelphia Pennsylvania
United States Providence Portland Medical Center Portland Oregon
United States Providence Orthopaedic Specialities Spokane Washington
United States Scott and White Hospital Temple Texas
United States Kansas Joint and Spine Institute Wichita Kansas

Sponsors (1)

Lead Sponsor Collaborator
Stryker Orthopaedics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stem Survivorship (%) Failure is defined by stem revision for any cause. 5 years Yes
Primary Femoral Stem Fracture 5 years Yes
Secondary Radiographic Stability Absence of a radiolucent lines = 2mm around the entire stem in AP or ML view. 5 years Yes
Secondary Harris Hip Score Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor.
90 - 100 = excellent
80 - 89 = good
70 - 79 = fair
0 - 69 = poor
pre-op and 5 years No
Secondary SF-36 Health Status Survey: Role - Physical Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state:
The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health
This Secondary Outcome Measure is focused on the "Role-Physical" score.
pre-op, 2 year and 5 year No
Secondary Post-surgery Femoral Crack/Fracture and Subsidence Rate Post-op to 5 years Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Recruiting NCT03746925 - Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches N/A
Completed NCT03008967 - A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark N/A
Completed NCT00980616 - Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA) Phase 2
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT04542174 - PMCF 8 Year Results TRJ®
Not yet recruiting NCT04019925 - Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis N/A
Recruiting NCT06102811 - Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty N/A
Recruiting NCT03570944 - Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Recruiting NCT02938962 - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X) Phase 4
Completed NCT03076827 - Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol N/A
Recruiting NCT02385383 - An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study N/A
Completed NCT01444586 - Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) N/A
Terminated NCT02525627 - A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads N/A
Completed NCT00808483 - Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty N/A
Terminated NCT00958347 - Omnifit Hydroxylapatite (HA) Hip Outcomes Study N/A
Completed NCT01422304 - Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) Phase 3
Completed NCT04332055 - RCT Measuring the Effect of the ERVIN Software N/A
Completed NCT01257568 - Rejuvenate Modular Outcomes Study N/A
Recruiting NCT01031732 - Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty N/A